Amneal Pharmaceuticals, Inc. ( AMRX) - Stock Earnings
AMRX Quarterly earnings
Analyst consensus estimates are available to paid members.
| Date | Earnings | Revenue |
|---|---|---|
| 2026Q1 | 62.3 million USD | 722.5 million USD |
| 2026Q2 | 57.7 million USD | 796.2 million USD |
| 2026Q3 | -7.5 million USD | 862.7 million USD |
| 2026Q4 Est. | — | — |
| 2027Q1 Est. | — | — |
| 2027Q2 Est. | — | — |
AMRX Yearly earnings
Analyst consensus estimates are available to paid members.
| Date | Earnings | Revenue |
|---|---|---|
| 2023 | -84.0 million USD | 2.4 billion USD |
| 2024 | -116.9 million USD | 2.8 billion USD |
| 2025 | 72.1 million USD | 3.0 billion USD |
| 2026 Est. | — | — |
AMRX
Price: $21.40
52 week price:
Payout Ratio Range:
Earnings Per Share: 0.40 USD
P/E Ratio: 53.20
Exchange: NMS
Sector: Healthcare
Industry: Drug Manufacturers - Specialty & Generic
Country: United States
Volume: 1.8 million
Market Capitalization: 7.4 billion